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Summary
We have analyzed how the immune system generates antibodies that are specific for analogues
of an epitope on the influenza virus hemagglutinin (HA) that differ solely by the presence of
Asp or Gly at amino acid 225 . Most antibodies induced in response to HA(Asp225) use one
of a few closely related variable (V) region structures that are encoded by characteristic VH/Vk
gene segment combinations. Remarkably, none of these VH/Vk combinations was induced in
response toHA(Gly225) . Instead of modifying the HA(Asp225)-specific V regions byjunctional
variation or somatic mutation to recognize the altered epitope, new VH/Vk combinations were
used. The expression of unique VH/Vk combinations appears to confer exquisite specificity to
the selection ofHAspecific B cells from the pre-immune repertoire.
n both B andT lymphocytes, specific recognition is medi-
ated through clonally distributed heterodimeric receptors.
For each type of receptor, two polypeptide chains are gener-
ated by somatic rearrangement of separate V, J, and in the
case ofVH andVA D gene segments (reviewed in reference
1) . Crystallographic analyses of antibody molecules have
demonstrated that the regions of greatest sequence variability,
called complementarity-determining regions (CDR), form
loops (2, 3) ; for each polypeptide, CDR1 and CDR2 are en-
coded by the V gene segment, whereas the junctionally en-
coded CDR3 is somatically generated during V(D)J gene
assembly (1, 4, 5). The spatial arrangement of the amino acid
residues in these loops establishes the specificity of antibody
molecules for protein molecules.
Previous studies have clearly demonstrated that somatic
alterations ofV region sequences byjunctional variation and
somatic mutation can play an important role in determining
the specificity of antibody molecules (6-8) . For example, so-
matic alterations of antibodies that recognize the influenza
virus A/PR/8/34 hemagglutinin (PR8 HA)' can influence
their interaction with the HA, as measured by their ability
to crossreact with mutant viruses that possess different amino
acid substitutions in the antibody combining site (9-14) . So-
matic alterations ofV region sequences can also change the
specificity of antibody molecules such that they recognize
different antigens. An example of this is the somatic muta-
tion of a phosphocholine-specific antibody to acquire specificity
forDNA (15) . Similarly, somatic mutation ofV region se-
I Abbreviations used in thispaper . HA, hemagglutinin ; HAU, hemaggluti-
nating units .
quences can alter antibody specificity for analogues ofthe hapten
arsonate (16) . However, the extent to which somatic altera-
tions of V region sequences can give rise to antibodies that
are specific for different protein antigens has been unclear.
This question is of particular interest in view of the exten-
sive interactions that take place in the combining site between
antibodies and protein epitopes. Analyses ofcomplexes formed
between antibodies and protein antigens have demonstrated
interactions between 15 and 22 amino acids on both the an-
tigen and the antibody molecule (17-23) . Nevertheless, single
amino acid substitutions that induce only minor local altera-
tions in the epitope can abolish antibody binding, and can
lead to the induction of noncrossreactive antibodies (22,
24-26) . How the immune system distinguishes between dis-
tinct analogues of epitopes that display such extensive struc-
tural similarity has not yet been explained.
We have addressed this issue by comparing hybridoma an-
tibodies that were induced in response to two HA molecules
that differ from each other solely by the presence ofAsp or
Gly at amino acid 225 . Based on this comparison, we have
assessed how antibodies that are specific for similar but not
identical overall shapes of determinant are generated . Even
though certain characteristicVH/Vk combinations were used
to recognize Asp225, none of these combinations was used
to recognize Gly225 . The results indicate that somatic alter-
ations of these characteristic VH/Vk combinations did not
provide the basis for distinguishing these epitope analogues,
and further suggest that the expression of specific VH/Vk
combinations can be critical in establishing the specificity of
antibodies for the HA . These findings also demonstrate the
capacity for single amino acid interchanges to influence the
immune recognition of viruses, such as influenza virus and
613
￿
J. Exp. Med . © The Rockefeller University Press " 0022-1007/91/09/0613/12 $2.00
Volume 174 September 1991 613-624HIV, which can accumulate numerous amino acid substitu-




HA-specific antibodies were generated
as described previouslyby fusion ofSP2/0-Ag14 myeloma cells with
splenocytes from BALB/c mice (Jackson Laboratories, Bar Harbor,
ME) (27) . In the hybridoma designation, the first number indi-
cates the fusion from which the hybridoma was derived ; for ex-
ample, H36-6 was derived from fusion H36 after immunization
with PR8 virus, whereas T1-107 was derived from fusion T1 after
immunization with mutant virus T3 . The PR8-specific hybridoma
antibodies were generated by various primary and secondary re-
sponse immunization protocols, as have been described elsewhere
(11, 27, 28) . The T3-specific hybridomas were generated after ei-
ther primary or secondary immunization of adult mice as follows.
For fusions T1, T2, T4, T7, T8, T9, and T10, mice were immunized
intravenously with 1,000 hemagglutinating units (HAU) of virus
T3, followed 5 d later by splenectomy and fusion . For fusions T5
and T6, mice were primed for 24 d and given a booster injection
3 d before death with 1,000 HAU by the intraperitoneal and intra-
venous routes, respectively. T3 HAspecific antibodies were idintified
as those that were able to bind the immunizing virus, but that
could not bind the reassortant virus Jl (which contains a serologi-
cally noncrossreactive HA) (27) . Culture supernatants were ana-
lyzed for their binding to purifiedT3 and J1 viruses in the ELISA
by detection first with a murine Ck-specific rat mAb/biotin re-
agent, then with extravidin-alkaline phosphatase (Sigma Chemical
Co ., St . Louis, MO), and finally developed withp-nitrophenyl phos-




of the PR8-specific antibodies has been described previously (11,
27, 30) . HAspecific hybridoma culture supernatants from the T3
fusions were first screened at two dilutions (1:5 and 1:25) for their
ability tobind 20HAU ofpurified viruses T3 andPR8 in the ELISA .
Antibodies that displayed more than twofold higher binding to
T3 than to PR8 in this primary screen were then cloned by limit
dilution . The ability ofculture supernatants to bind T3 and PR8
virus was then compared in serial dilution in the ELISA, and those
that displayed at least fourfold higher binding to T3 than to PR8
in the linear titration range were selected for sequence analysis .
Sequence Analysis ofHybridoma V Regions.
￿
Total cellular RNA
was prepared from hybridoma cell lysates and used to prepare cDNA
copies of Ig V regions using 12p-labeled constant region-specific
primers as described (11) . Full-length cDNA products were iso-
lated by PAGE, and VH and Vk region sequences were amplified
in the PCR using either degenerateV region primers that hybridize
to the 5' ends of many VH and Vk regions, or using one-sided
PCR, and were subjected to direct sequence analysis as described
(28) .
Results
Generation and Specificity Analysis ofPR8- and T3-specific
Hybridoma Antibodies. Virus T3 is a neutralization escape
mutant that differs from influenza virus PR8 by an Asp to
Gly interchange at amino acid 225 in the HA (10) . T3 is
one of 12 mutant viruses that define the antigenic region Ca,
containing amino acid substitutions that are closely located
on the surface of the H3 subtype HA (Fig. 1) . 16% of PR8
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Figure 1 .
￿
Location on the HA of amino acid 225 and of other amino
acids that define the Ca antigenic site . A side view of the crystallographic
structure of the H3 subtype HA trimer is shown (36); two of three
monomers from the trimer can be seen in this view. The Ca site spans
the interface between adjacent monomers (10) . The amino acid residues
that define the Ca antigenic site are shaded, and the location of amino
acid 225 is indicated.
HAspecific hybridomas display reduced or undetectable
binding to T3 (W. Gerhard, personal communication) . We
analyzed 27 hybridomas that bind to antigenic region Ca on
the PR8 HA for their VH and Vk region sequences : 19 of
these hybridomas fail to bind to mutant virus T3 (11, 30) .
The remaining Ca-specific hybridomas can bind to T3, but
fail to bind to one or more of the other mutant viruses that
have substitutions in this region (30) . The 19 hybridomas
that fail to bind toT3 were obtained from 12 individual donor
mice following a variety of primary and secondary response
immunization protocols . Since these antibodies can bind to
thePR8 HA (which contains Asp at residue 225) but display
reduced, and in most cases, undetectable binding to the T3
HA (which contains Gly at residue 225), we designate these
hybridomas as being PR8(Asp225) specific. The reaction of
several PR8(Asp225)-specific hybridomas with the PR8 and
T3 viruses in ELISA is shown in Fig. 2 .
We havenow generated a corresponding panel of T3(Gly-
225)-specific hybridoma antibodies. Nine individual BALB/c
mice were immunized with mutant virus T3 ; spleens were
removed 5 d after primary or 3 d after secondary immuniza-
















Specificity analysis ofPR8(Asp225)-specific and T3(Gly225)-
specific hybridoma antibodies. Serial dilutions ofculture supernatants from
representative hybridomas were incubated with 20 HAU each of purified
PR8 and T3 viruses adsorbed to polyvinyl plates, and antibody binding
was measured in ELISA .
hybridomas were screened first to identify those that were
T3 HA specific, and then for their ability to bind to the T3
and PR8 viruses ; 15% of the T3 HAspecific hybridomas
failed to bind to PR8 . 20 T3-specific hybridoma antibodies
were isolated that displayed reduced, and in most cases, un-
detectable binding to PR8 (Fig. 2) . Accordingly, the T3
(Gly225)-specific hybridomas recognize a region of the HA
that is related to the one recognized by the PR8(Asp225)-
specific hybridomas in that amino acid 225 is a crucial part
of the epitope, but Gly instead of Asp is required at amino
acid 225 .
Variable Region Expression among PR8- and T3-specific Hy-
bridoma Antibodies. The VH and Vk region nucleotide se-
quences of some of the PR8(Asp225)-specific hybridoma an-
tibodies have been described (11) . The VH and Vk region
nucleotide sequences ofthe remaining PR8(Asp225)-specific,
and ofthe T3(Gly225)-specific hybridomas areshown in Figs.
3 and 4 . The deduced amino acid sequences of the PR8
(Asp225)- and T3(Gly225)-specific hybridoma VH and Vk
regions are shown together in Figs. 5 and 6 . The sequences
have been grouped according to previously defined VH and
Vk gene families (31-34) ; the gene family from which each
hybridoma VH and Vk region was derived is listed in Table
1 . TheVH andVk gene families represent groups of similar
gene segments that share>80% sequence similarity. It should
be noted that even though a set of hybridomas might express
members of the sameVH or Vk gene family, they neverthe-
less can displaymany differences in their V region sequences.
For example, several VH genes derived from the J558 gene
family displayed quite different sequences. In some cases, how-
ever, sets of hybridomas expressedVH orVk sequences that
were identical or that differed by only one or two amino acids.
These hybridomas appear to utilizecommon germ-line gene
segments, as indicated by shared symbols in Table 1 .
The PR8(Asp225)-specific panel contains gene segments
drawn from five differentVH and five differentVk gene fam-
ilies . As shown in Table 1, these VH and Vk gene segments
did not associate in random combinations to generate the
PR8(Asp225) specificity. Indeed, the majority of the PR8
(Asp225)-specific hybridomas can be placed into one of four
groupsbased on theVH/Vk gene segment combination .Two
large groups utilized VH gene segments drawn from the 7183
gene family in conjunction with a unique gene segment from
the Vk1 or Vk24 gene families. A third group of three hy-
bridomas utilized a specific 36-60/VkP F gene segment com-
bination, and a pair ofhybridomas utilized a specificJ558/Vk1
gene segment combination . TheVk1 gene segment utilized
by this latter group is quite different (20 amino acid differ-
ences) from the Vk1 gene segment utilized in conjunction
with members of the 7183 family. These four VH/Vk gene
segment combinations make up 80% of the hybridoma panel
and are thus quite characteristic ofthe PR8(Asp225) response .
The overall number ofVH and Vk gene families utilized
by the T3(Gly225)-specific hybridoma.panel is similar to that
used in the PR8(Asp225) response. Members offive different
VH and seven different Vk gene families are expressed by
the T3(Gly225)-specific hybridomas . However, none of the
VH/Vk combinations characteristic of the PR8(Asp225)-
specific hybridomas was used in response to T3(Gly225) . In-
terestingly, some of the individualVH andVk gene segments
from the PR8(Asp225) combinations were used by T3(Gly-
225)-specific hybridomas. With only one exception, these gene
segments were expressed in association with a member of
a different VH orVk gene family to recognize T3(Gly225) .
The notable exception is hybridomaT5-334, which expresses
the sameJ558 gene segment as is utilized as part of the char-
acteristicJ558/Vk1 combination in the PR8(Asp225) response.
T5-334 utilizes this J558 gene segment in conjunction with
the Vk1 gene segment that associates with members of the
7183 gene family in the PR8(Asp225) response. In this case,
then, a novel reassortment of gene segments from the PR8
(Asp225) response appears to have provided the basis for es-
tablishing specificity for T3(Gly225) .
A small group of T3(Gly225)-specific hybridomas from
two different mice express an identical J558/Vk4/5 gene seg-
ment combination . As was observed with the characteristic
PR8(Asp225)-specificVH/Vk combinations, the individual
VH and Vk gene segments from this T3(Gly225)-specific
VH/Vk combination were utilized in the PR8(Asp225) re-
sponse. Once again, however, they were expressed in associa-
tion with gene segments from different VH and Vk gene
families to generate the alternate specificity .
The general lack ofoverlap in VH/Vk expression between
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ofVH regions from PR8(Asp225)-
and T3(Gly225)-specific hybrid-
omas . Sequences are grouped ac-
cording toVH gene family and are
displayed relative to a representative
from each group (e.g., T4-57 for the
J558 group; the deduced amino acid
sequence for each group represen-
tative is also shown) . Dashes indi-
cate identity with the representative
sequence . The deduced amino acid
sequence ofeach family representa-
tive is numbered according to Kabat
et al. (41) . The locations ofCDR
are also shown . Dots have been
introduced to facilitate alignment
of the sequences. The nucleotide
sequences of some of the PR8
(Asp225)-specific hybridomas have
previously been described (11) .
These sequence data and the data in




142, M64147, M64148, M64150,
M64152, M64153, M64155, M64-
159-M64161, M64166, M64167,
and M64169 .
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ofVk regions from PR8(Asp225)-
and T3(Gly225)-specific hybrid-
omas. Sequences are grouped ac-
cording to Vk gene family and are
displayed relative to a representative
from each group (e.g., Tl-107 for
theVk9 group; thededuced amino
acid sequence for each group repre-
sentative is also shown) . Dashes in-
dicate identity with the representa-
tive sequence. The deduced amino
acid sequence of each family repre-
sentative is numbered according to
Kabat et al. (41) . The locations of
CDR are also shown. Dots have
been introduced to facilitate align-
ment ofthe sequences, and ambigui-
ties are indicated byX . The nucleo-
tide sequences of some of the PR8
(Asp225)-specific hybridomas have
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in each panel. Even though three hybridomas from the
T3(Gly225) response express the same VH/Vk gene family
combinations as are expressed by three hybridomas from the
PR8(Asp225)-specific panel, the individual VH and Vk gene
segments that are used in each response display many differ-
ences that indicate their derivation from different germ-line
gene segments . The possibility that these represent somatic
variants of single germ-line gene segments can be excluded
because in most cases they are primary response hybridomas
that display little or no somatic mutation (6, 8) . The only
secondary response hybridoma among this group that could
potentially represent a somatic variant is T6-510 . However,
it displays a different length ofL chain CDR1 region that
indicates a distinct germ-line gene origin .
Discussion
Corresponding panels ofhybridoma antibodies were gener-
ated that recognize related structures on theHA in which
amino acid 225 forms a crucial part of the epitope, but that
differ in their requirement for Asp or Gly at this residue.
Many different V gene segments appeared to be used prefer-
entially in the PR8(Asp225)- and T3G(Gly225)-specific hy-
bridoma panels . Even though seven individual V genes were
used in both panels, they were always utilized as part of
different VH/Vk combinations in thetwo panels . Moreover,
a large proportion of the PR8(Asp225)-specific hybridomas
utilized one of four characteristic VH/Vk gene segment com-
binations. Remarkably, none of these combinations was uti-
lizedamong T3(Gly225)-specific antibodies. Despite the large
sequence variability that could potentially have been intro-
duced, particularly in the H chain CDR3, to alter the anti-
body paratopes, this mechanism was not used to generate
antibodies that distinguish this single amino acid interchange.
Instead, unique VH/Vk gene segment combinations were
used in each response.
The failure to observe somatically altered versions of the
characteristic PR8(Asp225) VH/Vk combinations among the
T3(Gly225)-specific hybridomas was unexpected. Both so-
matic mutation and junctional variation can influence how
antibodies interact with theHA, as measured by their ability
to recognize mutant viruses (such as T3) that contain single
amino acid substitutions (11-14) . In addition, the paratopes
of the PR8(Asp225)-specific antibodies described here can
all be distinguished based on their reactivities with mutant
viruses, and some of these differences in specificity for the
HA are likely to be the result ofjunctional variation or so-
matic mutation . For example, the sets of PR8(Asp225) hy-
bridomas that utilize the characteristic J558/Vkl and 36-
60/VkRF combinations each express identical VH and Vk
gene sequences, differing only in their junctional sequences
(Figs. 5 and 6) . Since these antibodies also display unique
reactivities with other PR8 mutant viruses (30), the junc-
tional sequences of these antibodies influence how they in-
teract with the HA . Why then was junctional variation not
utilized to modify the paratopes and allow recognition of
the structurally related region of T3(Gly225)? One possi-
bility is that thecharacteristic PR8(Asp225)-specific antibodies
bind to the HA with orientations that do not involve inter-
actions between thejunctional regions and residue 225 . Thus,
modifications of thejunctional regions would not affect rec-
ognition ofthe amino acid at residue 225 . Although this may
have provided a plausible mechanism to account for a single
VH/Vk combination, it seems less likely to explain the failure
ofjunctional variation to adapt any of four different PR8
(Asp225)-specific VH/Vk combinations to recognize T3
(Gly225) .
A second possibility is that although junctional variation
could potentially generate the alternate specificities, the ap-
propriate types of modification are rare. It was anticipated
that junctional variation would modify the specificity of some
of these VH/Vk combinations because it has the capacity
to introduce an enormous amount of sequence variation . Es-
timates of the size of the antibody repertoire generally in-
troduce factors of several orders of magnitude to account for
the number of differentjunctional sequences that can be ex-
pressed by any individual VH/Vk combination (see for ex-
ample references 1 and 8). It was anticipated that at least some
of the different junctional sequences from this vast potential
pool would modify the specificity of these antibodies. It is
significant, however, that these estimates predict total reper-
toire sizes that greatly exceed the number of lymphocytes
in a mouse. Thus, even ifjunctional variation has the capacity
to modify the PR8(Asp225) VH/Vk sequences and generate
specificity for T3(Gly225), these sequences may be so rare
that there is a low probability that any individualmouse would
contain aB cell that expresses the appropriate modification .
Figure 5 .
￿
Deduced amino acid sequences of PR8(Asp225)- and T3(Gly225)-specific H chain V regions. Hybridoms whose designation contains
the H prefix are PR8(Asp225) specific ; those whose designation contains the T prefix are T3(Gly225) specific. Sequences are grouped according to
theVH gene family from which they were derived (which is indicated), and are displayed relative to a representative sequence from that family (e.g .,
T4-57 for theJ558 group)'. Dashes indicate identity with the representative sequence . Within each family, V regions that display near identical amino
acid sequences and are likely to have been derived from the same VH gene segment are grouped together. Members of the 7183 gene family have
been grouped according to a previous characterization that included Southern hybridization analysis and the presence of shared silent substitutions
(11) . The H chain isotype, and the JH gene segment that is utilized are indicated . Also shown is the Vk gene family that each hybridoma expresses,
and the protocol used for immunization ; 1° indicates primary response, 2° indicates secondary response, and 1°n indicates hybridomas derived from
neonatal mice primed intravenously on day of birth followed by immunization and fusion at various times during the next few weeks . Although these
mice received two immunizations, they are referred to as primary response antibodies because there is no evidence that injection at birth primed HA-
responsive B cells (28) . The sequence of T4-57 is numbered according to Kabat et al. (41), and the location o¬CDR is indicated. Dots have been
introduced to facilitate alignment ofthe sequences. Two groups ofT3-specific hybridomas (T5-58 and T5-334 ; and T6-626, T6-416, and T6-112) express
identical CDR3 sequences, and therefore represent clonally related B cells (42) . This latter group utilizes identicalH and L chain nucleotide sequences
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For each hybridoma, the VH and Vk gene family that was utilized is shown . Closely related VH and Vk gene segments that are likely to have
been derived from the same germ-line gene segment are indicated by the same symbols . The hybridomas have been grouped together according
to theVH/Vk combinations they express . Where the same gene segment was utilized by both a PR8(Asp225)- and a T3(Gly225)-specific hybridoma,
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T5-131 Q52 VklThese findings may then illustrate the difficulty in defining
how distinct mechanisms contribute to the generation of the
immune repertoire based on estimates of potential diversity
that exceed the total lymphocyte pool of an individual .
In view of the failure of junctional variation to modify
the PR8(Asp225VH/Vk combinations, it is intriguing that
there are several examples in which specific VH/Vk pairing
appears to have provided the basis for generating these alter-
nate specificities . For example, the T3(Gly225)-specific hy-
bridoma T5-334 uses VH and Vk gene segments that are
drawn from characteristic PR8(Asp225)-specific hybridomas,
but does so in a novel pairwise combination that has not been
observed in the PR8(Asp225) response (see Table 1) . Hy-
bridoma T5-334 demonstrates that the absence of this com-
bination from the PR8(Asp225)-specific hybridoma panel is
not a consequence of the inability of this VH and Vk gene
to associate and produce an HAspecific antibody. Rather,
the pairing of this VH with this Vk gene segment appears
to influence the specificity of the resulting antibody, leading
to its utilization in the T3(Gly225) response. This model sug-
gests that the specificity of antibodies for the HA may be
exquisitely dependent on specific VH/Vk pairing, even to
the extent that junctional variation cannot modify these an-
tibody paratopes and create specificity for T3(Gly225) . Fu-
ture experiments in which these VH andVk gene segments
are reassorted in bacterial expression systems (35, 36) should
allow this model to be directly tested .
It remains possible that certainVH/Vk combinations have
the potential to acquire appropriate somatic mutations that
would allow them to interact with either T3(Gly225) or
PR8(Asp225) . The failure to identify somatic variants of the
characteristic PR8(Asp225)VH/Vk combinations among sec-
ondary response T3(Gly225)-specific hybridomas may in fact
reflect the specificity with which primary response B cells
were stimulated. Since none o£ the T3(Gly225)-specific
primary response hybridomas utilized the characteristicPR8
(Asp225) VH/Vk combinations, these combinations were
apparently not stimulated during primary immunization with
T3 . Hence, somatic variants of these combinations were not
obtained among the secondary response hybridomas. It may
therefore be possible to obtain T3(Gly225)-specific somatic
variants of the characteristic PR8(Asp225) VH/Vk combi-
nations by priming withPR8 followed by a secondary boost
with T3 . Experiments to address this possibility are in progress .
Central to this analysis is the postulate that the Asp to
Gly interchange at amino acid 225 does not induce major
structural alterations in the HA. Several lines ofevidence sug-
gest that this interchange is unlikely to impart a large effect
on the structure of the HA . Most importantly, a significant
number of HA-specific antibodies recognize the antigenic re-
gion Ca (in which residue 225 is located), and crossreact with
PR8(Asp225) and T3(Gly225) (10, 30) . These antibodies
recognize the same region of theHA as do the antibodies
described here, but the Asp to Gly interchange at residue 225
does not affect their binding, presumably because they do
not make important contacts with this residue . In addition,
the structures ofsevenHA and neuraminidase neutralization
escape mutants have been determined (22, 24-26) . In all cases,
escape mutants that differ by single amino acid interchanges
display only local structural alterations on the surface of the
molecule. In one of these comparisons, the effect of an Asp
to Gly interchange at residue 146 of the X-31(H3 subtype)
HA was examined (24) . This Asp to Gly substitution resulted
in a repositioning of the amino acid side chain over a range
of<1 X, and led to a >1,000-fold reduction in the binding
of the antibody used for selection . Residue 146 is located in
a loop on the HA (37) ; comparison of the antigenic struc-
ture ofPR8 with the crystallographic structure of the H3
subtype HA suggests that PR8 amino acid 225 is similarly
located on a loop and is exposed to solvent (10) . It seems
likely that a similar local conformational change in the HA
monomer was induced by the Asp to Gly interchange in virus
T3 . It may, however, be significant that the antigenic region
Ca spans the interface between adjacentHAmonomers (Fig .
1) . It is therefore possible that subtle conformational changes
in this region could nevertheless have a complex effect on
the antigenic structure of this site on the HA trimer. If this
indeed is the case, it remains intriguing that different pairings
of the sameVH and Vk gene segments were in some cases
utilized to generate the alternate specificities . A similar com-
parison of antibodies induced in response to PR8 and an es-
cape mutant from an antigenic region that does not span the
monomer interface (such as the site Cb) should allow this
possibility to be addressed .
Finally, it is significant to note that antigenic variability
is the prominent feature of the immune recognition of the
HA (as well as some other viruses, such as HIV) (38, 39) .
Influenza A viruses can escape the existing antiviral immu-
nity of the host population gradually (antigenic drift) by ac-
cumulating individual, serologically significant amino acid
differences (38) . For example, the mutation of Asp to Gly
at residue 225 has occurred during the evolution of the H1
subtype influenza virus in humans (40), and residue 225 is
one of at least 30 positions at which serologically significant
amino acid substitutions can occur on the H1 subtype HA
(10) . The dissimilarity between these two hybridoma panels
serves to demonstrate how relatively minor structural varia-
tion of the type that occurs during antigenic drift oftheHA
can nevertheless exert a considerable impact on the structural
and genetic basis by which a protein, or indeed, a virus, is
recognized by the immune system .
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